Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/24910
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/24910
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ATULYA DEODHAR

Listed Specialty: Rheumatology
3181 SW SAM JACKSON PARK RD, PORTLAND, OR, 97239-3011

2018 Payments: At a Glance

108

payments

$128,177

payment total

11

companies paid this doctor

Types of Payments

Category Payments Payment Value
Consulting
 24 $89,085
Travel and Lodging
 42 $36,069
Food and Beverage
 40 $3,000
Education
 2 $23

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
AIN457F

drug

 $34,835
TALTZ

drug

 $30,332
Payments with no listed product

N/A

 $23,469
ENBREL

drug

 $15,982
COSENTYX

drug

 $13,390
CIMZIA

drug

 $6,397
CFZ533X

drug

 $5,306
ILARIS

drug

 $5,306
XELJANZ

drug

 $3,538
DIOVAN

drug

 $643
HUMIRA

drug

 $217
KEVZARA

drug

 $16
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
Jun 17, 2018 $11,565 AIN457F Travel and Lodging NOVARTIS PHARMA AG
May 23, 2018 $9,788 AIN457F Consulting NOVARTIS PHARMA AG
May 11, 2018 $8,543 ENBREL Travel and Lodging PFIZER INC.
Jul 13, 2018 $8,000 No Listed Product Consulting UCB SA
Jul 26, 2018 $7,554 TALTZ Travel and Lodging ELI LILLY AND COMPANY
Aug 3, 2018 $7,300 TALTZ Consulting ELI LILLY AND COMPANY
Aug 28, 2018 $7,219 AIN457F Consulting NOVARTIS PHARMA AG
Jun 1, 2018 $6,540 ENBREL Consulting PFIZER INC.
Aug 14, 2018 $6,300 TALTZ Consulting LILLY USA, LLC
Nov 6, 2018 $6,000 No Listed Product Consulting ABBVIE, INC.
May 24, 2018 $5,841 COSENTYX Consulting NOVARTIS PHARMACEUTICALS CORPORATION
Aug 21, 2018 $5,192 CFZ533X COSENTYX ILARIS Consulting NOVARTIS PHARMA AG
Jan 8, 2018 $3,700 No Listed Product Consulting E.R. SQUIBB & SONS, L.L.C.
Nov 23, 2018 $3,360 CIMZIA Consulting UCB, INC. Atulya Deodhar
Jan 1, 2018 $3,300 XELJANZ Consulting PFIZER INC.
Aug 28, 2018 $3,200 No Listed Product Consulting E.R. SQUIBB & SONS, L.L.C.
Nov 23, 2018 $2,880 CIMZIA Consulting UCB, INC. Atulya Deodhar
Jan 5, 2018 $2,380 AIN457F Consulting NOVARTIS PHARMA AG
Jun 26, 2018 $2,100 TALTZ Consulting ELI LILLY AND COMPANY
Nov 13, 2018 $1,575 TALTZ Consulting ELI LILLY AND COMPANY

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/24910

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.